News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AngioDynamics (ANGO) to Present at the 24th Annual Piper Jaffray Healthcare Conference


11/19/2012 11:06:27 AM

ALBANY, N.Y., Nov. 19, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel in Manhattan. AngioDynamics' presentation will be at 10:30 a.m. Eastern Time, Wednesday, November 28, 2012. Joseph DeVivo, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments.

A live webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's Web site under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

Trademarks

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Contact:

Company Contact:

AngioDynamics, Inc.

D. Joseph Gersuk, CFO

(800) 772-6446 x1608

jgersuk@AngioDynamics.com

Investor Relations Contacts:

EVC Group, Inc.

Jamar Ismail/Robert Jones

(415) 568-9348; (646) 201-5447

jismail@evcgroup.com;

bjones@evcgroup.com

Media Contact:

EVC Group, Inc.

Chris Gale

(646) 201-5431

cgale@evcgroup.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES